Schaeffer's Top Stock Picks for '25

Options Bulls Pounce as Vanda Pharmaceuticals Inc. (VNDA) Gaps Higher

Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) stock volume is at a 52-week peak, while options are crossing at eight times the average pace

Aug 25, 2016 at 1:45 PM
facebook X logo linkedin


Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) is flying today -- up 18% at $13.85 -- and stock volume is at a 52-week peak. While no apparent news seems to be moving the shares, today's upside could partially be due to short sellers scrambling to cover, after VNDA notched a fresh 12-month peak of $15.24 earlier. Regardless, options are crossing at eight times what's typically seen at this point in the day -- and with call volume docked in the 99th annual percentile, a number of traders are betting on even more upside for VNDA stock in the near term.

Specifically, call options have the lead over put options by a more than 15-to-1 ratio. Most active are VNDA's September 11 and 12 call, as well as the October 15 call. It seems safe to assume new positions are being purchased, meaning the call buyers expect VNDA to settle north of the respective strikes at options expiration. Even if the calls finish out of the money (OOTM), though, the most the options buyers stand to lose is the initial premium paid.

More broadly speaking, traders are more call-heavy than usual among options set to expire in three months or less, per VNDA's Schaeffer's put/call open interest ratio (SOIR) of 0.27. Drilling down, the November 13 call is home to peak open interest among all VNDA positions, with 4,833 contracts in residence. According to Trade-Alert, it looks like the bulk of this activity was a result of speculators buying to open new positions on Aug. 10, when VNDA stock was trading in the $12.15-$12.60 range.

As touched upon, though, the equity is heavily shorted, and at VNDA's average daily pace of trading, it would take almost a full week to cover the 2.7 million shares that are sold short. In light of this, it's possible some of the recent call buying -- particularly at OOTM strikes -- is a result of short sellers hedging their bearish bets against any upside risk.

On the charts, today's positive price action is just more of the same for the stock. Since bottoming at a two-year low of $6.91 in mid-February, shares of Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) have doubled.

Sign up now for Schaeffer's Market Recap to get all the day's big stock movers, must-know technical  levels, and top economic stories straight to your inbox.
 
 

Which of These SUB-$5 Stocks Could 26x From Here? (AD)

He called a rare 11x on Tesla…

Then he called a 26x on Workhorse…

Then an even rarer 35x on Nio Inc…

Now Tim Bohen says these 5 tiny “America First” stocks are next up in 2025.

They’re trading for less than $5 right now.

But thanks to Elon & Trump’s new alliance…

They could be off to the races in Trump’s first 100 days.

And right now for a limited time…

You can get the names & tickers for just $1 here. (AD)

10 Stock Picks FREE
 
 

Featured Articles from Trusted Partners:

🚀 One Stock Pick Could Change Everything in 2025
What if one stock pick could define your success next year? Get 10 expert-vetted stocks set for 2025—plus 5 bonus picks to watch now. Get the Report →

🆕 New Options Need New Trading Strategies
Zero-DTE options are the newest (and hottest) options to trade.  Professional traders have rushed into the market and are making a mint.  Don’t get left behind - learn all about these options, how to trade them, market setups to profit from, plus much more. Download now →

👀 Revealed: 3 Defensive Stocks for Your Portfolio
Worried about the market? This free report reveals 3 under-the-radar defensive stocks for uncertain times in any kind of economy.

 

 
 

FREE Report Download

 

Follow us on X, Follow us on Twitter